Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Slim Fourati

Showing results (161-170 of 185) with videos related to

Pageof 19
Sort By:
Nature Communications|August 28, 2024
Administration of anti-HIV-1 broadly neutralizing monoclonal antibodies with increased affinity to Fcγ receptors during acute SHIV<sub>AD8-EO</sub> infectionJoana Dias, Giulia Fabozzi, Slim Fourati, et al.
Plos Neglected Tropical Diseases|July 5, 2023
Schistosoma mansoni infection alters the host pre-vaccination environment resulting in blunted Hepatitis B vaccination immune responsesRoshell Muir, Talibah Metcalf, Slim Fourati, et al.
Cell|July 8, 2021
Translocated microbiome composition determines immunological outcome in treated HIV infectionKrystelle Nganou-Makamdop, Aarthi Talla, Ashish Arunkumar Sharma, et al.
Plos Pathogens|July 6, 2021
Interleukin-15 response signature predicts RhCMV/SIV vaccine efficacyFredrik Barrenäs, Scott G Hansen, Lynn Law, et al.
Iscience|October 27, 2025
Integrative multi-omics analysis <i>in vivo</i> identifies influenza virus host factorsLeah P Shriver, Benjamin J Polacco, Manon Eckhardt, et al.
Nature Medicine|May 23, 2018
HIV vaccine candidate activation of hypoxia and the inflammasome in CD14<sup>+</sup> monocytes is associated with a decreased risk of SIV<sub>mac251</sub> acquisitionMonica Vaccari, Slim Fourati, Shari N Gordon, et al.
Nature Communications|October 12, 2022
Clinical phenotypes and outcomes associated with SARS-CoV-2 variant Omicron in critically ill French patients with COVID-19Nicolas de Prost, Etienne Audureau, Nicholas Heming, et al.
The Lancet. Infectious Diseases|October 17, 2024
Genotypic and phenotypic characterisation of respiratory syncytial virus after nirsevimab breakthrough infections: a large, multicentre, observational, real-world studySlim Fourati, Alawiya Reslan, Jérome Bourret, et al.
Nature Communications|December 8, 2022
Author Correction: Clinical phenotypes and outcomes associated with SARS-CoV-2 variant Omicron in critically ill French patients with COVID-19Nicolas de Prost, Etienne Audureau, Nicholas Heming, et al.
Annals of Intensive Care|June 14, 2024
Correction: COVID-19 associated pulmonary aspergillosis in critically-ill patients: a prospective multicenter study in the era of Delta and Omicron variantsPierre Bay, Etienne Audureau, Sébastien Préau, et al.
Pageof 19

Showing results (161-170 of 185) with videos related to

Sort By:
Pageof 19
Nature Communications|August 28, 2024
Administration of anti-HIV-1 broadly neutralizing monoclonal antibodies with increased affinity to Fcγ receptors during acute SHIV<sub>AD8-EO</sub> infectionJoana Dias, Giulia Fabozzi, Slim Fourati, et al.
Plos Neglected Tropical Diseases|July 5, 2023
Schistosoma mansoni infection alters the host pre-vaccination environment resulting in blunted Hepatitis B vaccination immune responsesRoshell Muir, Talibah Metcalf, Slim Fourati, et al.
Cell|July 8, 2021
Translocated microbiome composition determines immunological outcome in treated HIV infectionKrystelle Nganou-Makamdop, Aarthi Talla, Ashish Arunkumar Sharma, et al.
Plos Pathogens|July 6, 2021
Interleukin-15 response signature predicts RhCMV/SIV vaccine efficacyFredrik Barrenäs, Scott G Hansen, Lynn Law, et al.
Iscience|October 27, 2025
Integrative multi-omics analysis <i>in vivo</i> identifies influenza virus host factorsLeah P Shriver, Benjamin J Polacco, Manon Eckhardt, et al.
Nature Medicine|May 23, 2018
HIV vaccine candidate activation of hypoxia and the inflammasome in CD14<sup>+</sup> monocytes is associated with a decreased risk of SIV<sub>mac251</sub> acquisitionMonica Vaccari, Slim Fourati, Shari N Gordon, et al.
Nature Communications|October 12, 2022
Clinical phenotypes and outcomes associated with SARS-CoV-2 variant Omicron in critically ill French patients with COVID-19Nicolas de Prost, Etienne Audureau, Nicholas Heming, et al.
The Lancet. Infectious Diseases|October 17, 2024
Genotypic and phenotypic characterisation of respiratory syncytial virus after nirsevimab breakthrough infections: a large, multicentre, observational, real-world studySlim Fourati, Alawiya Reslan, Jérome Bourret, et al.
Nature Communications|December 8, 2022
Author Correction: Clinical phenotypes and outcomes associated with SARS-CoV-2 variant Omicron in critically ill French patients with COVID-19Nicolas de Prost, Etienne Audureau, Nicholas Heming, et al.
Annals of Intensive Care|June 14, 2024
Correction: COVID-19 associated pulmonary aspergillosis in critically-ill patients: a prospective multicenter study in the era of Delta and Omicron variantsPierre Bay, Etienne Audureau, Sébastien Préau, et al.
Pageof 19